China shares end higher, virus vaccine hopes boost healthcare stocks


SHANGHAI, July 21 (Reuters) - China shares ended higher on Tuesday, lifted by healthcare stocks as global hopes for a coronavirus vaccine firmed, but profit-taking following the previous session's rally checked gains.

** At the close, the Shanghai Composite index .SSEC was up 0.2% at 3,320.89, after flirting with small losses in the afternoon session. The index jumped 3.1% a day earlier.

** The blue-chip CSI300 index .CSI300 added 0.23% with the healthcare sub-index .CSI300HC soaring 3.95%, on rising global hopes for coronavirus vaccines following promising studies.

** The smaller Shenzhen index .SZSC gained 0.72% and the start-up board ChiNext Composite index .CNT was 1.45% higher.

** Around the region, MSCI's Asia ex-Japan stock index .MIAPJ0000PUS was firmer by 1.89%, while Japan's Nikkei index .N225 closed up 0.73%.

** At 0701 GMT, the yuan CNY=CFXS was quoted at 6.9911 per U.S. dollar, 0.01% firmer than the previous close of 6.9915.

** The largest percentage gainers in the main Shanghai Composite index were Jiangsu Highhope International Group Corp 600981.SS, up 10.12%, followed by BEH-Property Co Ltd 600791.SS, gaining 10.12% and Ningxia Xinri Hengli Steel Wire Rope Co Ltd 600165.SS, up by 10.08%.

** The largest percentage losses in the Shanghai index were of Xinjiang Youhao Group Co Ltd 600778.SS down 10.06%, followed by Xishui Strong Year Co Ltd Inner Mongolia 600291.SS and Luyin Investment Group Co Ltd 600784.SS, both down 9.97% each.

** So far this year, the Shanghai stock index is up 8.9% and the CSI300 has risen 14.5%, while China's H-share index listed in Hong Kong is down 6.7%. Shanghai stocks have risen 11.26% this month.

** As of 0702 GMT, China's A-shares were trading at a premium of 32.79% over Hong Kong-listed H-shares.

** So far this week, the market capitalisation of the Shanghai stock index has risen by 3.20% to 38.00 trillion yuan ($5.44 trillion).

($1 = 6.9900 Chinese yuan renminbi)

(Reporting by Andrew Galbraith; Editing by Rashmi Aich)

((; +86 21 2083 0079; Reuters Messaging: ; Twitter:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.